Insignificant increase in A1C in those with and without diabetes after COVID-19 infection
There is statistically significant but clinically insignificant increase in A1c in people following COVID-19 infection in both those with and without diabetes, according to a new retrospective, observational, case-control study of more than 20,000 people from a single US medical center.
The study has shown a statistically significant but clinically insignificant increase in A1c in people following COVID-19 infection, in both those with and without diabetes. Further after receiving a diagnosis of COVID-19 infection patients were 40% more likely to also receive a diagnosis of type 2 diabetes compared with people who tested negative for COVID-19, a difference that was significant and could be explained by the increased medical care received by people who test positive for COVID-19. The study published in medRxiv.org further found that risk of incident diabetic ketoacidosis (DKA) among people who tested positive for COVID-19 was significantly higher among those with preexisting type 2 diabetes, those using insulin, and among Black individuals.
Until now the impact of COVID-19 infection on A1c remained unclear. Results from previous studies indicated that COVID-19 infection may increase A1c levels, but the studied cohorts were small and lacked uninfected controls.
In the study researchers retrospectively selected patients with an A1c recorded within 12 months before their COVID-19 test as well as a second A1c value recorded within 12 months after COVID-19 testing. This produced a study cohort of 8755 COVID-positive people and 11,998 matched people who tested negative for COVID-19. Thea data came from a Cleveland Clinic registry that included 81,093 people who tested positive for COVID-19 between March 2020 and May 2021 and 153,034 matched individuals who tested negative for COVID-19 during the same period. The authors identified two sub-cohorts that excluded those with a history of DKA. The sub-cohorts were 701 people with type 1 diabetes, and 21,830 with type 2 diabetes to evaluate risk of DKA.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.